“Moderate” adjuvant chemotherapy-induced leukopenia is beneficial for survival of patients with early breast cancer: A retrospective study

The association between chemotherapy-induced leukopenia (CIL) and survival for patients with early breast cancer (EBC) is not known. We investigated the relationship between different grades of CIL and survival in patients with EBC receiving adjuvant chemotherapy.